Model informed assessment of QT prolongation during drug development: a five-year retrospective analysis of EMA scientific advices
{{output}}
Regulatory evaluation of QT interval prolongation remains central to cardiac safety assessment in drug development. Since the 2015 revision of the ICH E14 Q&A, concentration-QT (C-QT) modelling has been formally recognized as an acceptable alternative to dedic... ...
